New Technology Grant Program 2002 - 03
Information for Applicants
The New Technology Grant Program for 2002-03 will comprise:
- New Grant funding;
- A second year of funding (if applied for) for items funded in 2001-02
and not covered by casemix in 2002 -03; and
- Extended (beyond a 2nd year) funding of items previously supported
through this Program which are not incorporated into casemix and/or
are not funded by the Commonwealth. The amount for each Hospital/Health
Service will be proportional to their 2001-02 rollover
allocation and will provided as a block payment. Submissions
are not required.
This year, co-payments for AAA stents and Atrial Septal
Defect closure devices are likely to be included in casemix. In this
case, these items will no longer be funded under the New Technology grant.
Additionally, trastuzumab (Herceptin) is now eligible for Commonwealth
funding and will also not be funded within the New Technology grant
program.
Criteria
To be considered for funding, submissions must meet the following
criteria:
1. A new procedure or practice introduced during the past two
years. This may include:
- Prostheses or implantable devices
- Drugs
- Diagnostic tests; and
- Medical/Surgical procedures.
2. Of proven efficacy and have demonstrated improvement
in either (or both) clinical outcome or reduction in long term health
costs.
3. Demonstrated to have significant costs not incorporated into the
2002-03 cost weights.
4. Demonstrated evidence of operator credentialing and competency
where a new procedure or use of a new prosthesis is involved.
5. A minimum cost for each submission of $20,000.
Additional information for applications
- Funding is available only for the conduct of the actual procedures
or practices;
- It is anticipated that funding will be predominantly for WIES-based
services, though other funding streams (eg VACS) are not excluded;
- The grant will be for one year;
- A second year of funding may be available;
- A part funding contribution may be provided if applications exceed
the available funding;
Exclusions
Funding is not applicable to:
- Service enhancements;
- Equipment;
- Research;
- Information technology;
- Pharmaceuticals covered by S100 arrangements;
- Drugs which are being used to treat conditions other than those approved
by the TGA; or
- Prostheses or devices not approved for marketing in Australia by the
TGA.
Essential information required
It is essential that applications include:
- Evidence of efficacy and demonstrated improvement in clinical outcome
and/or long-term health care costs
- Details of any operator credentialing and competency
- Details of any internal assessment by a New Procedures/Practice/Technology
or Pharmaceutical Advisory Committee or equivalent
- Evidence of endorsement and support by the Health Service/Hospital
CEO.
Submission of applications
A New Grant Proforma (
Word File 40KB ) or Proforma for a 2nd Year Grant
(
Word File 32KB) must be completed for each individual submission. A Health
Service/Hospital Submission Summary (
Excel File 19KB) must also be completed for New and 2nd Year Grant submissions.
Submissions for extended funding will not be required
An original set of prioritised submissions including summary tables
plus 4 collated sets of submissions, all unbound, are required
for New and 2nd Year Grants. It is important for submissions to be fully
completed in accordance with the proforma. A soft copy of New and 2nd
Year Grant submissions, and the Hospital/Health Service Summary is also
required. This will facilitate timely processing and assessment of submissions.
Submissions should be addressed to Dr Mary B Turner, Senior Medical Advisor,
Metropolitan Health and Aged Care Services, Department of Human Services,
Level 10, 589 Collins Street, Melbourne 3000 and are to be received by
11 July 2002. Health Services/Hospitals will be notified of the
outcome by early September 2002.
Assessment of submissions
Submissions will be assessed by a panel comprising officers of the Department
of Human Services and external parties with expertise in evidence based
assessment. It should be noted that nominated referees will not be required
in the application; however, the applicant may be requested to provide
referees at a later date.
There will be limited ability to assess submissions with incomplete information
or that are non compliant with the proforma. Also, the ability to request
further information will be limited.
Enquiries
Enquiries can be directed to Dr Arona Offenberger, Medical Fellow, on
03 9616 2143 or Email arona.offenberger@dhs.vic.gov.au.
|
